You cannot apply for this job anymore (deadline was 25 Sep 2017).
Browse the current job offers or choose an item in the top navigation above.
Within the Ion Transport group of the department of Physiology, we are seeking a Postdoc for a combined genetic, molecular and physiological project entitled "Majestic magnesium: a molecular gateway to new therapies" which is funded by an VICI grant from ZonMW. We offer a challenging postdoc project in a well-organized, international, and high-profile department within the Radboud Institute for Molecular Life Sciences.
Magnesium (Mg2+) is of central importance for a wide variety of physiological processes in our body, including intracellular signaling, neuronal excitability, muscle contraction, bone formation and it acts as essential cofactor in numerous enzymatic reactions. The overall Mg2+ balance is tightly regulated by the concerted actions of the intestine, bones and kidneys, which keep plasma Mg2+ levels within a narrow physiological range. Deficiencies in the Mg2+ balance result in serious health problems including tetany, ataxia, seizures, neuromuscular abnormalities and cardiac arrhythmias that can lead to sudden death. Mg2+-related disorders can be inherited in which magnesiotropic genes have been mutated or acquired in which drugs or environmental circumstances severely affect the Mg2+ status.
Over the last years we have identified new magnesiotropic genes but the functionomics of several transporters remains unclear. Interestingly, hypomagnesemia, and its complications, has also been reported to occur at high frequency among patients with diabetes mellitus type 2. Despite reports linking hypomagnesemia to chronic diabetic complications, attention to this issue was thus far underestimated. There are signs that Mg2+ plays an important role in the onset and progression of the disease. Recent data from my group provided the first evidence that mutations in the renal epithelial Mg2+ channel may play a role. This project aims to investigate rare and acquired disorders to unravel (patho)physiological Mg2+-related processes in the human body.
The following key objectives will be addressed:
• Identification of new magnesiotropic genes
• Functionomics of recently identified and new magnesiotropic genes
• Mg2+ as a risk factor in major diseases
• Innovative methodologies to measure Mg2+ movement
Tasks:
Fixed-term contract: 1 year, with a possible extension to three years.
Radboudumc strives to be a leading developer of sustainable, innovative and affordable healthcare to improve the health and wellbeing of people and society in the Netherlands and beyond. This is the core of our mission: To have a significant impact on healthcare. To get a better picture of what this entails, check out our strategy film.
Our key strength is medical life-sciences and clinical practice, with an impressive infrastructure comprising state-of-the-art technology platforms and (translational) research facilities. The Radboudumc is therefore uniquely positioned in the emerging Euregio and Dutch healthcare infrastructure to play a leading role in the new healthcare paradigm of prediction, prevention and personalised medicine.
The Radboudumc focuses on scientific health challenges of today, with an eye on emerging diseases of the future.
Read more about what it means to work at Radboudumc and how you can do your part.
The department of Physiology has a long-standing tradition in transport physiology in epithelia and has build up a substantial know-how and infrastructure in the field of molecular and cellular physiology of water and electrolyte transport. The department is, together with basic science and research-oriented clinical departments of the Radboud University Medical Center, housed in the Radboud Institute for Molecular Life Sciences (www.RIMLS.nl), which integrates diverse scientific expertises in molecular and medical science for the advancement of innovation in translational research.
We like to make it easy for you, sign in for these and other useful features: